TrialAnnals of clinical microbiology and antimicrobials2026
An ultra-sensitive cell-free DNA-based diagnostic assay for Tuberculous pleurisy utilizing the CRISPR-Cas13a system.
Weicong Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.